Newlink Genetics reported 92.64M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Agenus AGEN:US $ 290.48M 41.49M
Bristol Myers Squibb BMY:US $ 30121M 3141M
Capricor Therapeutics CAPR:US $ 59.63M 23.2M
Celldex Therapeutics CLDX:US $ 390.7M 20.14M
Eli Lilly And LLY:US $ 16964.7M 1487.7M
Idera Pharmaceuticals IDRA:US $ 29.36M 4.68M
Intrexon XON:US $ 154.94M 1.69M
Merk MRK:US $ 31184M 918M
Nektar Therapeutics NKTR:US $ 733.46M 62.13M
Newlink Genetics NLNK:US 92.64M 7.03M
Pfizer PFE:US $ 54420M 5273M
Prothena PRTA:US 555.62M 29.19M
Sarepta Therapeutics SRPT:US $ 2530.95M 73.15M
Vascular Biogenics VBLT:US 46.52M 8.33M
YTE INCY:US $ 3288.09M 169.42M